Evicenter
P&T meetings

Cytisinicline

Smoking cessation

Last updated
86 sources

Company-reported prevalence

Cytisinicline

Overview

FieldValue
DrugCytisinicline
IndicationSmoking cessation
DiseaseNicotine dependence: adults who smoke combustible cigarettes, adults who use e-cigarettes, and those who want to quit or attempt to quit
CompanyAchieve Life Sciences (development and commercialization rights in the United States, under an exclusive license and supply agreement with Sopharma AD); Sopharma AD (licensor; markets cytisinicline in Central and Eastern Europe)
Documents searchedAchieve Life Sciences website, home page and references page, October 2026; Achieve Life Sciences website, products page, October 2026; Achieve Life Sciences corporate presentation, July 2026; Achieve Life Sciences Form 10-K for 2025, filed March 2026; Achieve Life Sciences Form 10-K/A for 2025, 2026; Achieve Life Sciences press releases of October 7, 2026, October 6, 2026, October 1, 2026, September 28, 2026, August 2026 (second quarter 2026 results), May 19, 2026, 2026 (complete response letter), and September 3, 2025 (NDA acceptance)
Data as ofOctober 14, 2026
Prepared byAI research agent (Claude); not yet reviewed by a person

Company statements of prevalence

United States

Europe

No evidence found.

Global

Other countries and regions

No evidence found.

Geography not stated

Sources the company cites

Agaku 2026

Park-Lee 2026

VanFrank 2024

Vahratian 2025

Jamal 2024

Centers for disease control and prevention 2026a

Centers for disease control and prevention 2026b

National center for health statistics 2026

Passage carrying the figure

Not quoted: The cited source is an interactive query of the National Health Interview Survey that a person must run; it has no fixed passage to quote.

Achieve life sciences 2021

Passage carrying the figure

Not quoted: The Form 10-K names a company survey presented at the 2021 Society for Research on Nicotine and Tobacco Annual Meeting without a title, authors, or address, and no copy of the presentation was found.

References